- Blood plasma therapy not useful for seriously ill patients
- The study was carried out in 72 hospitals
Convalescent plasma does not reduce the risk of death in patients suffering from COVID-19, according to a study. People receiving the therapy are found to be experiencing more adverse events as compared to the ones who are receiving standard care.
Tags : Clinical, Trial, Hospitals, Patients, Infection,